Collection of Tissue Samples for Cancer Research
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)
- Status
- COMPLETED
- Phase
- PHASE2
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q
- Status
- UNKNOWN
- Phase
- PHASE2
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
- Status
- TERMINATED
- Phase
- PHASE2
FTS Study in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
- Status
- TERMINATED
- Phase
- PHASE1
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)
- Status
- COMPLETED
- Phase
- PHASE3
RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Collection and Banking of Leukemia Cells MDS/AML
- Status
- COMPLETED
- Phase
- NA